دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
A wake-up call for sleep in rheumatic diseases
doi : 10.1016/S2665-9913(22)00311-3
Volume 4, Issue 11, November 2022, Page e739
Suspending methotrexate for 2 weeks after COVID-19 vaccination
doi : 10.1016/S2665-9913(22)00265-X
Volume 4, Issue 11, November 2022, Pages e740-e741
Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease
doi : 10.1016/S2665-9913(22)00256-9
Volume 4, Issue 11, November 2022, Pages e741-e743
Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes
doi : 10.1016/S2665-9913(22)00229-6
Volume 4, Issue 11, November 2022, Pages e743-e745
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
doi : 10.1016/S2665-9913(22)00221-1
Volume 4, Issue 11, November 2022, Pages e747-e750
Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
doi : 10.1016/S2665-9913(22)00251-X
Volume 4, Issue 11, November 2022, Pages e751-e752
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
doi : 10.1016/S2665-9913(22)00228-4
Volume 4, Issue 11, November 2022, Pages e755-e764
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
doi : 10.1016/S2665-9913(22)00227-2
Volume 4, Issue 11, November 2022, Pages e765-e774
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study
doi : 10.1016/S2665-9913(22)00216-8
Volume 4, Issue 11, November 2022, Pages e775-e784
Monkeypox associated acute arthritis
doi : 10.1016/S2665-9913(22)00257-0
Volume 4, Issue 11, November 2022, Page e804
